Business
Amazonas Hemp Ltd. Announces Update On The Completion of Its First Product That Will Be Launched In January And Receipt of First Pre-Orders
Amazonas Hemp Ltd. Announces Update On The Completion of Its First Product That Will Be Launched In January And Receipt of First Pre-Orders.
About this update from Amazonas Florestal Ltd
[{"type":"text","content":"\n\n MIAMI, FL, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Amazon Hemp Ltd. (www.azhempusa.com) a wholly owned subsidiary of Amazonas Florestal Ltd. (www.azflusa.com) (OTC: PINK: AZFL), a natural resources company dedicated to innovative, sustainable forest management, Industrial CBD Hemp and the certification and sales of carbon credits, today announced an update on the completion of its CBD products formulations and the expected launching date for its first products.\n Amazon Hemp Ltd. reported that consumer product testing is advancing on schedule for completion next week on 12/27/2017, results thus far have been positive and the company continues on time for the launching of the first products in January 2018. The Company also reported that it has received its first substantial purchase order for $100,000 US to deliver products in January to Bonsai Med Spa Inc. The new account supplies doctors offices throughout South Florida. Company formulators have also reported advances in the second product to be launched in February. The company is using innovative tinctures and flavors that it expects will provide a top quality alternative to those CBD products found on the market today, many of which have not enjoyed the best success for lack of taste and strength of effectiveness. The Company is taking all of the necessary measures to ensure its product is proven through comprehensive consumer testing prior to beginning mass sales next year [AF1] [AF2]. The testing is being done since the week after Thanksgiving and the company formulators are confident based on the results so far that the products to be launched will be successful and widely accepted on the market. One of the formulators quoted said, “Our products are top of the line, no expense was barred or considered too much by Management in their orders and budget for formulation of product. We expect them to have an excellent degree of acceptance on the market.” The Company announced last week that it will launch the first product in 30 ml dropper bottles containing the recommended amount of 1ml daily for 30 days in potencies of 250mg and500 mg. The first product promotes Sleep and Relaxation and when used as indicated as a daily dietary supplement can alleviate stress, the silent killer affecting millions and raising the risk of contracting many other ...